drleonmartin Profile Banner
Leonardo Martin Profile
Leonardo Martin

@drleonmartin

Followers
44
Following
369
Media
15
Statuses
59

I develop and apply methods and concepts of molecular biology to regenerative medicine | PHYSPHAR @UAntwerpen | @ERA4Health_EU @HorizonEU Cofund @FWOVlaanderen

Joined July 2023
Don't wanna be here? Send us removal request.
@drleonmartin
Leonardo Martin
11 months
๐ŸŽ–๏ธHonored to receive the Young Researcher Award from @EatrisEric at their Annual Conference in Bulgaria! @EatrisBulgaria ๐Ÿ‡ช๐Ÿ‡บ๐Ÿงฌ๐Ÿ’Š๐Ÿ’‰ Excited to continue collaborating and advancing translational medicine for the future of healthcare.
0
0
2
@drleonmartin
Leonardo Martin
5 months
Proud to share our contribution to @NatRevCardiol ๐Ÿซ€
@NatRevCardiol
Nature Reviews Cardiology
5 months
New online! CD40โ€“CD40L: a milestone in the recognition of atherosclerosis as an immune disease
0
0
0
@drleonmartin
Leonardo Martin
9 months
โญ๏ธHonored to Welcome Prof. Peter Libby! We had the privilege of an insightful discussion with Prof. Libby @harvardmed and @BrighamWomens during his tour across Belgium. Tks to The Princess Lilian Foundation and Prof. DeMeyerโ™ฅ๏ธ๐Ÿฉบ๐Ÿ”ฌ#cardiovasculardisease #cardiology #inflammation
0
0
1
@drleonmartin
Leonardo Martin
10 months
Happy to be part of this collaborative effort for new discoveries on muscle repair! ๐Ÿ’ช๐Ÿƒ๐Ÿ”ฌ https://t.co/vSc07yiJWZ โ€ข @aossm1972 @aossmjournals @StilhanoS @FCMSCSP @UAntwerpen @Physphar @MYOTWlTTER #myotwitter #muscle #tissueregeneration #orthopedic #sportsmedicine
0
1
3
@drleonmartin
Leonardo Martin
11 months
Our latest study in STOTEN reveals TBBPA as an environmental immunotoxicant, disrupting membrane homeostasis in myeloid cells, key to innate immunity. These findings open doors for further toxicology & in vivo research. Thx Pulaski Lab @NCN_PL https://t.co/bpRccCYRM9
0
0
0
@HaploiPS
HAPLO-iPS
1 year
A Young Researchers Group was established under @HaploiPS that offers a platform for early-career scientists to collaborate, receive mentorship, and develop essential skills. Learn more about the goals of the YRG and its leaders at:
0
2
3
@HaploiPS
HAPLO-iPS
1 year
The MC of Haplo-iPS Cost Action CA21151 met online to review the progress of the network and discuss future plans for the next year of the project. The progress of each working group and planning of future activities was presented by the WG leaders and co-leaders. @HaploiPS
0
1
1
@drleonmartin
Leonardo Martin
1 year
Thank you Prof. Ilze Bot for hosting the CARDINNOVโ€ขMASTer kick-off at @UniLeidenNews - Excited to explore the key role of #mastcells in #hemorrhage & acute #cardiovascular #diseases through the #CardInnov_E4H initiative under @ERA4Health_EU
0
1
1
@drleonmartin
Leonardo Martin
1 year
๐‰๐จ๐ข๐ง ๐Ž๐ฎ๐ซ ๐“๐ž๐š๐ฆ ๐š๐ญ ๐ญ๐ก๐ž ๐”๐ง๐ข๐ฏ๐ž๐ซ๐ฌ๐ข๐ญ๐ฒ ๐จ๐Ÿ ๐€๐ง๐ญ๐ฐ๐ž๐ซ๐ฉ! ๐๐ก๐ƒ position on '๐•๐š๐ฌ๐œ๐ฎ๐ฅ๐š๐ซ ๐€๐ ๐ž๐ข๐ง๐  ๐š๐ง๐ ๐‚๐š๐ซ๐๐ข๐จ๐ฏ๐š๐ฌ๐œ๐ฎ๐ฅ๐š๐ซ ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž' - Prof. Dr. Lynn Roth ๐Ÿซ€๐Ÿ”ฌApply by: August 7, 2024 --> Here: https://t.co/33xGi210wR #PhDposition
0
0
2
@drleonmartin
Leonardo Martin
1 year
Join us in shaping the future of #innovative #therapies! We just launched the Research Topic on 'Advancements in Therapeutic Strategies for #Skeletal #Muscle and #Cardiovascular Diseases'. Submit manuscripts directly to @FrontiersIn Pharmacology: ๐Ÿ‘‰ https://t.co/K9MwecwvJI
0
0
1
@drleonmartin
Leonardo Martin
2 years
๐Ÿƒโ€โ™‚๏ธ๐Ÿคธโ€โ™‚๏ธAerobic physical #training helps manage severe #asthma by reducing #inflammation and improving #lung #health through the inhibition of kinin signaling. From Prof. Vieira's Lab now #openaccess at Mol. Biol. Rep. @SpringerNature #myotwitter #exercise https://t.co/oAm2ggUkYT
0
0
2
@drleonmartin
Leonardo Martin
2 years
We just started our 3rd meeting @HaploiPS in #Amsterdam to discuss the generation of human iPS cells from haplo-selected blood bank samples - HAPLO-iPS โ€ข COST ACTION CA21151 #haploips #CA21151 ๐Ÿš€๐Ÿงฌ๐Ÿ”ฌ๐Ÿฅ
0
3
6
@drleonmartin
Leonardo Martin
2 years
Fresh start! Thank you for the opportunity to share my background and now take up the new position during the PHYSPHAR meeting at the @AcademieMed #PhysPhar #Cardinnov @ERA4Health_EU @HorizonEU @FWOVlaanderen
0
0
1
@TENET_COST
TENET COST Action
2 years
๐Ÿ”Š Opens today! ๐Ÿค“ โžก๏ธ Call for Short Term Scientific Mission (STSM) Grants; โžก๏ธ Call for ITC Conference Grants for Young Researchers; โžก๏ธ Call for Dissemination Conference (DC) Grants. Check our website for application guidelines & deadlines:
1
5
5
@drleonmartin
Leonardo Martin
2 years
๐Ÿ“ขIt's time to meet the researchers on #amines and #polyamines, #cytokines, #amino #acids, #cannabinoids and #New #Drug #Application.ย We invite you to the 19th Congress of PTBH โ€ข Hope to see you all in๐Ÿ“#Poland 24-26 OCTOBER 2024!
0
0
1
@drleonmartin
Leonardo Martin
2 years
We are pleased to invite you to register for the #Bradykinin Symposium & #Angioedema School taking place in Berlin from 5 to 6 September 2024. Online registration is now open! --> https://t.co/9EFVDiAAvf Hope to see you all in #Berlin!โš•๏ธ๐Ÿ’‰๐Ÿซ€๐Ÿซ๐Ÿง ๐Ÿงฌ๐Ÿงช๐Ÿ”ฌ๐Ÿฉบ๐Ÿ’Š
0
0
0
@drleonmartin
Leonardo Martin
2 years
The Brazilian Health Regulatory Agency (Anvisa) approves first gene therapy product to treat hemophilia A in Brazil. ๐Ÿฉธ๐Ÿ’‰๐Ÿงซโš•๏ธ| The Brazilian Association of Cell and Gene Therapy (ABTCel-Gen) - @ISCTglobal https://t.co/RW5lCJXDb9
0
0
0
@drleonmartin
Leonardo Martin
2 years
#Development and manufacture of #SoHO and #ATMP, here we come! ๐Ÿš€ Thx @HaploiPS and @BSTRecerca for giving us the #basis for the #manufacture of #pharmaceutical-grade #iPSCs for #clinical translation | HAPLO-iPS โ€ข COST ACTION CA21151๐Ÿ“@donarsang
0
1
4
@ISSCR
ISSCR
2 years
#ISSCR just launched a new resource for patients & the public. https://t.co/KYQnf81alT is your go-to for accessible & reliable information on stem cell research & treatments. Explore the site & share with your family and friends. #aboutstemcells ๐Ÿ‘‰ https://t.co/25EZAQ90F8
0
16
24